Riskpilot← Back to searchSign inGet full accessCentMed Ab
OYActiveY-tunnus 3478941-7Hovrättsesplanaden 15Retail sale of medical and orthopaedic goods · NACE 4774Est. 2024— employees
Revenue 2025
EUR 1,3M
EBITDA margin
29.7%
Equity ratio
83.5%
Financial strength
Net profit 2025
EUR 315K
| Revenue | EUR 1,3M | — |
| EBITDA | EUR 394K | — |
| Net profit | EUR 315K | — |
| Total assets | EUR 378K | — |
| Equity | EUR 315K | — |
| Employees | — | — |
Legal name
CentMed Ab
Y-tunnus number
3478941-7
Legal form
Osakeyhtiö
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
27. syyskuuta 2024
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Bolagets verksamhet omfattar detalj- och partihandel, import, export och tillverkning av preparat och produkter, såsom naturkostprodukter, naturpreparat, kosmetika och kemikalievaror, som relaterar till hälsovård.
Även konsultering, produktutveckling och utförande av marknadsförings-tjänster i anslutning till läkemedels- och apoteksbranschen ingår i verksamheten samt hälso- och sjukvårdstjänster.
Bolagets verksamhet är även att sköta juridiska ärenden.
I bolagets verksamhet ingår även att äga och bedriva handel med värdepapper och bostads- och fastighetsaktiebolags aktier samt att äga, bedriva handel och hyra ut fastigheter och lägenheter.
Address
Hovrättsesplanaden 15
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2025 |
|---|---|
| Revenue | 1 326 |
| Staff expenses | −0 |
| EBITDA | 394 |
| Depreciation & amort. | −0 |
| EBIT | 394 |
| Net financials | 0 |
| Profit before tax | 394 |
| Tax | 79 |
| Net profit | 315 |
| Item | 2025 |
|---|---|
| Total assets | 378 |
| Equity | 315 |
| Long-term debt | 0 |
| Short-term debt | 62 |
| Total debt | 62 |
EBITDA margin
29.7%
This company
15.8%
Market median
+88% vs market
20252025
Equity ratio
83.5%
This company
38.2%
Market median
+119% vs market
20252025
Return on equity
100.0%
This company
18.4%
Market median
+443% vs market
20252025
Net profit margin
23.8%
This company
8.1%
Market median
+194% vs market
20252025
Asset turnover
3.51×
This company
1.12×
Market median
+213% vs market
20252025
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20252025
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
MM | Audit | 2024 |
RY Chief Executive Officer | Chief Executive Officer | 2024 |
JK Deputy Member | Deputy Member | 2024 |
HJ Deputy auditor | Deputy auditor | 2024 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CentMed Ab also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Minna Marianne Peräkorpi | Audit | 0 companies |
| Rita Yvonne Kjellman | Chief Executive Officer | 0 companies |
| Jakob Kristian Kjellman | Deputy Member | 0 companies |
| Hans Jan Anders Jåfs | Deputy auditor | 0 companies |